• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM

CHIMERIC THERAPEUTICS LIMITED

0.00% ! 0.3¢
Market Cap $9.747M  !

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company,... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CHM 08:09 22 7.2K
08:09 Last post  Aliasdavejay Comments Created with Sketch.  22  Views Created with Sketch.  7.2K 
CHM 07/08/25 0 278
07/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  278 
CHM 07/08/25 0 232
07/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  232 
CHM
TIME FOR CHANGES
03/08/25 56 11K
03/08/25 Last post  1MRX Comments Created with Sketch.  56  Views Created with Sketch.  11K 
CHM
CLTX-CAR T is a game changer
2
31/07/25 88 45K
31/07/25 Last post  stockrock Comments Created with Sketch.  88  Views Created with Sketch.  45K 
CHM
Chimeric: Media Thread
16 17 18
31/07/25 1.0K 444K
31/07/25 Last post  abitlikeme Comments Created with Sketch.  1.0K  Views Created with Sketch.  444K 
CHM 30/07/25 1 712
30/07/25 Last post  ThePig Comments Created with Sketch.  1  Views Created with Sketch.  712 
CHM 30/07/25 6 1.9K
30/07/25 Last post  F18FDG Comments Created with Sketch.  6  Views Created with Sketch.  1.9K 

See All Discussions arrow Created with Sketch.

Timeline

Notification regarding unquoted securities - CHM
07 Aug 17:22
 
Application for quotation of securities - CHM
07 Aug 17:19
 
CHM CDH17 Clinical Trial Update
04 Aug 08:58
 
Change in substantial holding - PH
29 Jul 17:05
 
Quarterly Activities/Appendix 4C Cash Flow Report
29 Jul 11:34
 
Proposed issue of securities - CHM
28 Jul 16:56
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.747M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.858K 619.3K

Buyers (Bids)

No. Vol. Price($)
66 58647032 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 107164382 32
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.